Conditions: Cystic Fibrosis Pancreatic Exocrine Insufficiency
Keywords: Cystic Fibrosis Pancreatic Exocrine Insufficiency
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 19
Healthy volunteers: no

Brief summary:
This study will assess the safety and tolerability of pancrelipase delayed release capsules in subjects up to 6 years of age with Pancreatic Exocrine Insufficiency (PEI) due to Cystic Fibrosis.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Pancrelipase Delayed Release
Intervention descriptions: intervention 1: 3,000, 6,000 and 12,000 unit Lipase Capsules

Protocol document: